BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16472176)

  • 1. Towards newer molecular targets for chronic diabetic complications.
    Khan ZA; Farhangkhoee H; Chakrabarti S
    Curr Vasc Pharmacol; 2006 Jan; 4(1):45-57. PubMed ID: 16472176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus, oxidative stress and advanced glycation endproducts].
    Bonnefont-Rousselot D; Beaudeux JL; Thérond P; Peynet J; Legrand A; Delattre J
    Ann Pharm Fr; 2004 May; 62(3):147-57. PubMed ID: 15243348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products and diabetic complications: a general overview.
    Peppa M; Vlassara H
    Hormones (Athens); 2005; 4(1):28-37. PubMed ID: 16574629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of carbonyl stress in the development of diabetic complications].
    Makk-Merczel K; Szarka A
    Orv Hetil; 2019 Oct; 160(40):1567-1573. PubMed ID: 31565977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic complications in diabetes mellitus.
    Kikkawa R
    Br J Nutr; 2000 Dec; 84 Suppl 2():S183-5. PubMed ID: 11242466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.
    Brings S; Fleming T; Freichel M; Muckenthaler MU; Herzig S; Nawroth PP
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous metabolic route for diabetic patients.
    Nogueira-Machado JA; Chaves MM
    Expert Opin Ther Targets; 2008 Jul; 12(7):871-82. PubMed ID: 18554155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies.
    Adeshara KA; Diwan AG; Tupe RS
    Curr Drug Targets; 2016; 17(11):1309-28. PubMed ID: 26648059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes.
    Hu XF; Wang L; Xiang G; Lei W; Feng YF
    Acta Biomater; 2018 Jun; 73():470-487. PubMed ID: 29649637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycotoxins in the diet promote diabetes and diabetic complications.
    Vlassara H; Striker G
    Curr Diab Rep; 2007 Jun; 7(3):235-41. PubMed ID: 17547841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.
    Pugazhenthi S; Qin L; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1037-1045. PubMed ID: 27156888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis.
    Lalla E; Lamster IB; Drury S; Fu C; Schmidt AM
    Periodontol 2000; 2000 Jun; 23():50-62. PubMed ID: 11276765
    [No Abstract]   [Full Text] [Related]  

  • 16. Lilly Lecture 1993. Glycation and diabetic complications.
    Brownlee M
    Diabetes; 1994 Jun; 43(6):836-41. PubMed ID: 8194672
    [No Abstract]   [Full Text] [Related]  

  • 17. The cellular and molecular mechanisms of diabetic complications.
    King GL; Brownlee M
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.
    Meerwaldt R; Links T; Zeebregts C; Tio R; Hillebrands JL; Smit A
    Cardiovasc Diabetol; 2008 Oct; 7():29. PubMed ID: 18840258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in diabetes.
    Yamagishi S; Nakamura K; Matsui T; Takenaka K; Jinnouchi Y; Imaizumi T
    Mini Rev Med Chem; 2006 Mar; 6(3):313-8. PubMed ID: 16515470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAGE (toxic AGEs) theory in diabetic complications.
    Sato T; Iwaki M; Shimogaito N; Wu X; Yamagishi S; Takeuchi M
    Curr Mol Med; 2006 May; 6(3):351-8. PubMed ID: 16712480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.